Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 456

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 456
---
 LLC, an affiliate of Gaius, was appointed as managing member of the Sponsor. On October 31, 2024, the PIPE Equity Subscription Agreement was amended to decrease the PIPE Investor’s committed purchase of PIPE Shares from 2,500,000 to 1,500,000, decrease the PIPE Equity Investment from $25,000,000 to $15,000,000. On November 1, 2024, the Company obtained additional advances under the Liminatus unsecured promissory note of $300,000, which resulted in a total outstanding principal balance of $3,418,500. On November 5, 2024, $28,672 was deposited into the Trust Account representing an Extension Payment. The Extension Payment was deposited from the Company’s operating account and is Due from Sponsor. On November 27, 2024, the Liminatus unsecured promissory note was amended and restated to increase the aggregate principal amount to up to $5,000,000.

F-25

TABLE OF CONTENTS

### IRIS ACQUISITION CORP

### NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
On December 2, 2024 and January 7, 2025, the Company obtained additional advances under the Liminatus unsecured promissory note in the total amount of $500,000 which resulted in a total outstanding principal balance of $3,918,500.

The Loan was settled and deemed paid in full on December 29, 2024.

On December 20, 2024, in connection with the Special Meeting, stockholders holding 64,453 public shares properly exercised their right to redeem their shares at a redemption price of approximately $11.47 per share (subject to adjustment for taxes payable from the trust account), for an aggregate redemption amount of approximately $739,195. The redemptions were paid on January 7, 2025.

On December 26, 2024, the parties to the Business Combination Agreement amended the Business Combination Agreement to extend the date by which the Business Combination Agreement can be terminated in the event the business combination has not been consummated to June 30, 2025.

On December 26, 2024, the parties to the PIPE Equity Subscription Agreement entered into an amendment to such agreement to extend the termination date of the agreement to June 30, 2025.

On December 26, 2024, the Company filed with